{"id":"soluvit","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"018ce289-f134-4951-b8b9-a02f6ae6af70","title":"SOLUVITA SODIUM FLUORIDE DROPS (SODIUM FLUORIDE) LIQUID [PATRIN PHARMA]"},"ecosystem":[],"_scrapedAt":"2026-03-28T00:08:48.899Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07105202","phase":"PHASE4","title":"Shorter Weaning From Invasive Ventilation With Levosimendan","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2025-09-17","conditions":"Mechanical Ventilation, Weaning Failure","enrollment":250},{"nctId":"NCT04020263","phase":"PHASE3","title":"Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock","status":"RECRUITING","sponsor":"Pr Bruno LEVY","startDate":"2023-07-03","conditions":"Cardiogenic Shock","enrollment":610},{"nctId":"NCT01500785","phase":"PHASE4","title":"Intracoronary Administration of Levosimendan in Cardiac Surgery Patients","status":"TERMINATED","sponsor":"Tampere University Hospital","startDate":"2018-06-15","conditions":"Myocardial Stunning","enrollment":50},{"nctId":"NCT03576677","phase":"PHASE4","title":"Effect of Levosimendan or Placebo on Exercise in Advanced Chronic Heart Failure","status":"UNKNOWN","sponsor":"Finn Gustafsson","startDate":"2019-08-01","conditions":"Heart Failure","enrollment":42},{"nctId":"NCT03355079","phase":"PHASE4","title":"Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy","status":"TERMINATED","sponsor":"Fresenius Kabi","startDate":"2018-02-28","conditions":"Cancer-related Malnutrition","enrollment":2},{"nctId":"NCT00994825","phase":"PHASE4","title":"Levosimendan in High Risk Patients Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"Università Vita-Salute San Raffaele","startDate":"2009-11","conditions":"Low Cardiac Output Syndrome","enrollment":1000}],"_emaApprovals":[],"_faersSignals":[{"count":19,"reaction":"NAUSEA"},{"count":18,"reaction":"DYSPNOEA"},{"count":17,"reaction":"PYREXIA"},{"count":12,"reaction":"DIARRHOEA"},{"count":11,"reaction":"BACTERAEMIA"},{"count":11,"reaction":"DECREASED APPETITE"},{"count":11,"reaction":"MALAISE"},{"count":10,"reaction":"ABDOMINAL PAIN"},{"count":10,"reaction":"DEATH"},{"count":10,"reaction":"PRODUCT PREPARATION ERROR"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":8,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Soluvit","genericName":"Soluvit","companyName":"Radboud University Medical Center","companyId":"radboud-university-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}